ICU Medical Q2 2024 Adj. EPS $1.56 Beats $1.00 Estimate, Sales $596.455M Beat $553.700M Estimate
Portfolio Pulse from Benzinga Newsdesk
ICU Medical (NASDAQ:ICUI) reported Q2 2024 adjusted EPS of $1.56, beating the $1.00 estimate by 56%. Sales were $596.455M, surpassing the $553.700M estimate by 7.72%. Despite the earnings beat, EPS decreased by 17.02% from last year, while sales increased by 8.58%.
August 07, 2024 | 8:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ICU Medical reported strong Q2 2024 earnings with an EPS of $1.56, beating estimates by 56%. Sales also exceeded expectations, reaching $596.455M. However, EPS decreased by 17.02% from the previous year.
The strong earnings and sales beat are likely to positively impact ICUI's stock price in the short term. However, the year-over-year decrease in EPS may temper some of the enthusiasm.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100